These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32125004)

  • 21. Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.
    Pac L; Horwitz MM; Namutebi AM; Auerbach BJ; Semeere A; Namulema T; Schwarz M; Bbosa R; Muruta A; Meya DB; Manabe YC
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):e69-76. PubMed ID: 25761234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania.
    Magambo KA; Kalluvya SE; Kapoor SW; Seni J; Chofle AA; Fitzgerald DW; Downs JA
    J Int AIDS Soc; 2014; 17(1):19040. PubMed ID: 25109284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining urine antigen and blood polymerase chain reaction for the diagnosis of disseminated histoplasmosis in hospitalized patients with advanced HIV disease.
    Vidal JE; Werlang PC; Muniz BM; Rego CM; Barbalho RE; Baptista AM; Telles JP; da Cruz AB; Pereira IS; Gava R; Marcusso R; Pasqualotto AC; Pereira-Chioccola VL
    Med Mycol; 2021 Sep; 59(9):916-922. PubMed ID: 33962466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnitude of Cryptococcal Antigenemia among HIV Infected Patients at a Referral Hospital, Northwest Ethiopia.
    Derbie A; Ayalew W; Mekonnen D; Alemu M; Mulugeta Y
    Ethiop J Health Sci; 2018 Jul; 28(4):369-374. PubMed ID: 30607049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic.
    Reepalu A; Balcha TT; Yitbarek T; Jarso G; Sturegård E; Björkman P
    BMC Res Notes; 2015 Nov; 8():702. PubMed ID: 26597840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No association of cryptococcal antigenemia with poor outcomes among antiretroviral therapy-experienced HIV-infected patients in Addis Ababa, Ethiopia.
    Smitson CC; Tenna A; Tsegaye M; Alemu AS; Fekade D; Aseffa A; Blumberg HM; Kempker RR
    PLoS One; 2014; 9(1):e85698. PubMed ID: 24465651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Looking for fungi in all the right places: screening for cryptococcal disease and other AIDS-related mycoses among patients with advanced HIV disease.
    Greene G; Sriruttan C; Le T; Chiller T; Govender NP
    Curr Opin HIV AIDS; 2017 Mar; 12(2):139-147. PubMed ID: 28134711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts.
    Pongsai P; Atamasirikul K; Sungkanuparph S
    J Infect; 2010 Jun; 60(6):474-7. PubMed ID: 20347868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.
    Jarvis JN; Lawn SD; Vogt M; Bangani N; Wood R; Harrison TS
    Clin Infect Dis; 2009 Apr; 48(7):856-62. PubMed ID: 19222372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
    Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
    Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
    BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in central american people living with HIV.
    Caceres DH; Arauz AB; Flores C; Santiago E; Montoya S; Saenz C; Torres-Meneses FA; Peralta H; Zuniga-Moya JC; Lainez Arteaga IZ; Garcia A; Abdo J; Verweij PE; Chiller TM; Forno D
    Mycoses; 2021 Nov; 64(11):1396-1401. PubMed ID: 33966300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Cryptococcal Antigen Testing in Immunosuppressed HIV-positive Children and Adolescents.
    Zuma P; Ramsamy Y; Mlisana K; Archary M
    Pediatr Infect Dis J; 2020 Mar; 39(3):217-220. PubMed ID: 31725553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility and Acceptability of Cryptococcal Antigen Screening and Prevalence of Cryptocococcemia in Patients Attending a Resource-Limited HIV/AIDS Clinic in Malawi.
    Chipungu C; Veltman JA; Jansen P; Chiliko P; Lossa C; Namarika D; Benner B; Hoffman RM; Bristow CC; Klausner JD
    J Int Assoc Provid AIDS Care; 2015; 14(5):387-90. PubMed ID: 26139095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
    Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
    Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou/Benin].
    Ogouyèmi-Hounto A; Zannou DM; Ayihounton G; Ahouada C; Azon-Kouanou A; Acakpo J; Sissinto Savi de Tove Y; Kinde Gazard D
    J Mycol Med; 2016 Dec; 26(4):391-397. PubMed ID: 27641486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
    Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
    Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic fungal infections in patients with human inmunodeficiency virus.
    Rodríguez-Cerdeira C; Arenas R; Moreno-Coutiño G; Vásquez E; Fernández R; Chang P
    Actas Dermosifiliogr; 2014; 105(1):5-17. PubMed ID: 23107866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated cryptococcosis and histoplasmosis co-infection in a HIV-infected woman in France.
    Ferry T; Ponceau B; Gaultier JB; Piens MA; Biron F; Picot S; Chidiac C; Peyramond D
    J Infect; 2005 Oct; 51(3):e173-6. PubMed ID: 16230201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.